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We present here the anatomy and histopathology of kidneys
from 11 patients with renal stones following small bowel
resection, including 10 with Crohn’s disease and 1 resection
in infancy for unknown cause. They presented predominantly
with calcium oxalate stones. Risks of formation included
hyperoxaluria (urine oxalate excretion greater than 45mg
per day) in half of the cases, and acidic urine of reduced
volume. As was found with ileostomy and obesity bypass,
inner medullary collecting ducts (IMCDs) contained crystal
deposits associated with cell injury, interstitial inflammation,
and papillary deformity. Cortical changes included modest
glomerular sclerosis, tubular atrophy, and interstitial fibrosis.
Randall’s plaque (interstitial papillary apatite) was abundant,
with calcium oxalate stone overgrowth similar to that seen in
ileostomy, idiopathic calcium oxalate stone formers, and
primary hyperparathyroidism. Abundant plaque was
compatible with the low urine volume and pH. The IMCD
deposits all contained apatite, with calcium oxalate present
in three cases, similar to findings in patients with obesity
bypass but not an ileostomy. The mechanisms for calcium
oxalate stone formation in IMCDs include elevated urine and
presumably tubule fluid calcium oxalate supersaturation, but
a low calcium to oxalate ratio. However, the mechanisms for
the presence of IMCD apatite remain unknown.
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We have shown elsewhere1,2 that bowel disease can produce a
wide range of renal histopathology and entrain multiple
mechanisms for renal stone production and formation of
intrarenal crystal deposits. In patients with obesity bypass
procedures, calcium oxalate (CaOx) stones are found free in
the urinary collecting system. Within the kidney, the only
deposits are occasional apatite plugs within inner medullary
collecting ducts (IMCDs), rare microscopic linear deposits of
CaOx over apical surfaces of otherwise normal-appearing
IMCD cells, and a single small IMCD CaOx plug in each of
two of the five cases that we have studied.1,2 Patients with
ileostomy produce stones containing both uric acid and
CaOx.3 In their kidneys, we have found interstitial apatite
(Randall’s) plaque, and IMCD plugs composed of apatite and
the sodium and ammonium acid salts of uric acid.3 Some
CaOx stones were found growing over regions of plaque, as is
seen in idiopathic CaOx stone formers (ICSFs) and stone
formers (SFs) with primary hyperparathyroidism.4–6 Other
stones were found free in the collecting system.
We have little difficulty in explaining the plaque, stones,
and urate IMCD deposits that we have thus far encountered
in bowel patients. Bypass patients produce no excess of
plaque above control subjects and their stones never grow
attached to renal papillae. The lack of plaque is consistent
with our earlier findings that plaque is promoted by scanty
acidic urine and hypercalciuria; bypass patients have high
urine volumes and are not hypercalciuric.1,7 Their urine
oxalate excretion is high, and we can presume with reason-
able certainty that hyperoxaluria (urine oxalate excretion
445mg per day) increased urine supersaturation (SS) with
respect to CaOx and led to crystal formation, perhaps in free
solution. By contrast, ileostomy patients produce scanty and
acidic urine, form abundant plaque, and produce attached
CaOx stones over areas of papillary plaque. Their urine has a
high uric acid SS that accounts for their uric acid stones.
Urine sodium and ammonium urate SS was present in three
of the five ileostomy patients with these salts in their IMCDs,
indicating that, for urate species, IMCDs and urine were not
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discordant. Altogether, the types of stones formed by bypass
and ileostomy patients that we have presented to date, as well
as urate IMCD deposits, can be reasonably explained by their
urine SS, and plaque abundance has seemed to follow urine
volume, calcium, and pH as in ICSFs and normal subjects.
What we cannot easily explain is the discordance between
apatite IMCD deposits and both urine SS and compositions
of stones formed. Though CaOx makes up the bulk of stones
in bypass patients, and they are hyperoxaluric, apatite is the
predominant IMCD crystal,2 even though their average urine
pH was below 5.5, and, correspondingly, their SS with respect
to calcium phosphate (CaP) was below 1. Discordance is even
greater with ileostomy. Although stones were composed of
uric acid and CaOx, urine pH was low, and CaP SS was well
below 1, apatite was the predominant IMCD crystal. In other
words, in both diseases, the IMCD environment seems to
produce and support apatite that would not be stable or
predicted in their urine. Stones reflect the urine conditions,
whereas IMCD deposits do not.
Discordance is by no means the rule. ICSFs have very
modest CaP SS in urine and never produce any IMCD crystal
deposits.2 Brushite SFs have higher urine CaP SS and produce
IMCD apatite deposits;8 the same is true for SFs with primary
hyperparathyroidism5,9 or distal renal tubular acidosis.10
Hence, apatite deposits can occur, or not, in accord with
urine SS; it is in our two bowel diseases that we have
encountered a unique disconnect between urine and IMCD,
the tubule fluid of which must closely approximate the final
urine under normal circumstances.
One way to advance the problem is to study additional
groups of patients with bowel disease, in the hope that within
the groups, we will eventually be able to discern mechanisms
for the dissociation of IMCD apatite from final urine
conditions and from stones. In this study, we present our
work on 11 patients who form CaOx stones and have small
bowel resection due to mainly Crohn’s disease. For the first
time, we can, in some patients, identify sizable IMCD CaOx
deposits that are consistent with both urine SS and the stones
being formed. However, in these deposits, we also always find
apatite, as unexpected as in ileostomy and bypass patients.
The details of these patients, taken along with those from
bypass and ileostomy patients, lead to an initial hypothesis
that might be of value for future research into the
mechanisms for IMCD deposit formation, and complete
present knowledge of crystal formation in tissues of SFs with
bowel disease. In addition, these patients form interstitial
plaque, and their urine findings support our past work
indicating that scanty and acidic urine can promote plaque in
the absence of overt hypercalciuria.
RESULTS
Clinical findings
In total, 11 patients were studied (Table 1); most patients
were men and all but one (case 3) had Crohn’s disease. Bowel
surgeries numbered from one to seven procedures; the
amount of bowel resected is not known to us. None had
ileostomy or colostomy. Stone formation began before or
after the surgery with a wide variation in timing (Table 1).
Numbers of stones and procedures were often quite high.
Serum creatinine values were not elevated; metabolic acidosis
and hypokalemia were not observed. Stones were over-
whelmingly CaOx monohydrate.
Surgical pathology
A majority of papillae contained large deposits of white,
interstitial apatite, plaque (Figure 1a–d, 2a and b). Abun-
dance of white plaque ranged from 1.2 to 14.9% of surface
area coverage, with a mean of 5±1 (Table 2). Some stones
were found attached to papillae in all but one case (patient
11) (Figure 1c, 2a and b; Table 2); when detached, they were
found to grow over white plaque, as is found in ICSFs,
primary hyperparathyroidism, and ileostomy patients.3–5 All
attached stones were composed of CaOx, with typical apatite
deposits adherent at sites at which stones were attached to
papillae (Figure 2c–e). In some regions, the density of
attached stones over plaque was remarkable and similar to
that found in ICSFs (Figure 2b).
Intermixed with white plaque, we observed ample yellow
plaque (Figure 1b and c), which is the gross reflection of
IMCD crystal plugs (Figure 1b–d). Crystal plugs protrude
Table 1 | Clinical characteristics and serum chemistries
Patient Sex
Age at first SB
surgery (years)
Age at first
stone (years)
Earlier
stones (no.)
Age at biopsy
(years) ESWL PNL
Total
procedures
Serum
creatinine (mg/dl)
Serum
CO2 (mmol/l)
Serum K
(mmol/l)
1 M 23 47 4 48 1 1 3 1.3 32 4.1
2 F 31 40 412 52 2 1 4 0.9 27 3.6
3 M 1 12 430 38 3 1 5 0.8 28 4.1
4 M 22 20 425 43 2 2 5 1.0 25 3.6
5 M 34 26 410 49 1 5 8 0.9 32 4.0
6 M 22 28 3 34 2 1 3 0.9 27 4.5
7 M 39 39 3 48 2 1 5 1.0 26 4.3
8 M 24 24 450 60 1 2 7 1.1 33 4.7
9 F 26 34 412 54 5 6 12 0.8 28 4.5
10 M o40 o40 410 75 0 5 5 1.0 27 4.3
11 M 40 47 1 52 3 2 6 0.8 28 4.7
Abbreviations: ESWL, extracorporeal shock wave lithotripsy; K, potassium; PNL, percutaneous nephrolithotomy; SB, small bowel.
Total procedures include cystoscopy, open surgery, ureteroscopy, as well as ESWL and PNL.
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(Figure 1b–d) from mouths of dilated Bellini ducts (BDs).
Dilated BDs were most abundant in flattened and deformed
papillae (Table 2). The amount of deformity was less than
that found in brushite SFs,8 but greater than that found in
ileostomy patients.
Histopathology
Intraoperative papillary microbiopsies revealed very large
amounts of interstitial plaque (Figure 3a–c). As predicted
from the operative appearance, multiple IMCDs were
plugged with crystal deposits (Figure 3c, d and 4a–f; Table 2).
Patterns of deposit vary from patient to patient. Three
patients (Table 2, cases 1, 8 and 9) have a higher number of
deposits than other patients. Two patients who do not have a
large number of deposits (Table 2 cases 4 and 10),
nevertheless, formed deposits of unusually large size (Figure
4a, b, e and f); because the deposits are large, their plugged
ducts occupy most of whole regions of papillary tissue in the
biopsy sample, to an extent only thus far encountered in
renal tubular acidosis and brushite nephropathy.8,10 Even so,
the overall density of plugging, estimated from microcom-
puted tomography (m-CT) images (Table 2), is less than that
which we have found in ileostomy patients. As usual, we
found no inflammation around even extensive interstitial
deposits; however, around plugged IMCDs, we found marked
interstitial inflammation and fibrosis (Figures 3d and 4a–f).
Cortical changes (Table 2) included moderate glomerular
sclerosis in all but two cases of patients (patients 5 and 10)
who had global sclerosis of a majority of glomeruli. Tubular
atrophy and interstitial fibrosis ranged from mild to
moderate and did not track closely with glomerular sclerosis
(Table 2). Serum creatinine (Table 1) did not reflect cortical
changes. No cortical deposits were detected.
Nature of crystal deposits
All patients had some IMCDs with nonbirefringent crystal
deposits, as would be found with apatite (Table 2). Although
crystals in most IMCDs were exclusively nonbirefringent, in
three patients (cases 2, 4, and 10; Table 2), we found some
IMCDs containing both birefringent and nonbirefringent
crystals. In fact, the IMCD plugs with both crystals contained
mixtures of CaOx and apatite. Using micro-FTIR (fourier-
transformed infrared spectroscopy), birefringent deposits
*
*
*
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Figure 1 |Coexistence of attached stones and Bellini duct (BD)
plugging on the same papillae. (a) Large area of white
interstitial (Randall’s) plaque (single arrows) on one papilla. (b) In
another patient, a large area of white plaque (single arrow) is seen
intermixed with areas of yellow plaque (inner medullary collecting
duct (IMCD) crystal deposits, arrowheads) and crystalline plugs
(asterisks) protruding from dilated BD. (c) A papilla from another
patient shows a smaller area of white plaque (single arrow)
intermixed with yellow plaque (arrowheads), BD plugs (asterisk),
and an attached stone (double arrows). (d) At higher
magnification, a dilated BD is seen with a protruding crystal plug
(asterisk) near several small areas of white plaque (single arrows).
a
c d e
b
Figure 2 |Details of attached stones. (a) An attached stone
(double arrow) is seen resting on a region of white plaque (single
arrows) and intermixed with small areas of white (single arrow)
and yellow plaques (arrowheads). (b) Patient 8 had numerous
attached stones (double arrow) atop an extensive area of white
plaque (single arrows) similar to that found in some idiopathic
calcium oxalate stone formers (ICSFs). Analysis of attached stones
by microcomputed tomography (m-CT) revealed these to be
composed of primarily calcium oxalate (CaOx), with small sites of
apatite corresponding to a site of attachment to white (Randall’s)
plaque. (c, d) Light microscopic image of an attached stone
revealing the smooth urinary (c) and papillary (d) surface
morphology. The papillary surface (d) shows a concave region
with crystalline material (single arrow) consistent with an
attachment site. The urinary surface (c) shows a damaged region
(double arrow) generated during stone removal. (e)
Reconstruction of m-CT images shows regions of CaOx in yellow
and areas of apatite in white. The white regions appear to present
at the attachment site.
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were always found to be composed of CaOx (Figure 5
illustrates case 4). Nonbirefringent deposits were always
composed of apatite (Figure 5 illustrates case 3). Because we
have made these positive determinations by FTIR, we have
labeled deposits in Table 2 by their crystal structure and not
by their optical appearance. Although present in the same
plugs, CaOx and apatite were never admixed together, but
occupied separate regions (Figure 4a–f).
Urine chemistry findings
Urine CaOx SS was quite high in most of the patients
(Table 3), the exceptions being cases 4, 8, and 9. Uric acid SS
was substantial in cases 6, 7, and 10; no stones contained uric
acid. One patient (Table 3, case 9) had some ammonium acid
urate in one stone. At the time of our study, the high urine
volume and unexceptional urine ammonia level did not
create a high SS with respect to that of salt (not shown).
Table 2 | Surgical and pathological findings and stone type
Patient
Papillary
deformity (%)
Plaque papillary
surface area (%)
Stones attached
to plaque
Dilated
BD
IMCD BD
deposits
Nature of
IMCD crystals Glom
Tub
At IF Stone type
1 100 4.80 Yes +++ 6±2 HA — — — COM (2)
2 33 3.60 Yes ++ 2±1 HA, CaOx 19/1/2/4 1 1 COM (1)
3 10 3.03 Yes + 1±1 HA 33/1/0/2 2 2 COM (1)
4 10 6.38 Yes + 2±1 HA, CaOx — — — COM (2)
5 75 2.62 Yes ++ 2±1 HA 12/0/1/11 2 2 CaOx 91%, HA 9% (5)
6 10 14.90 Yes + 1±1 HA 10/2/1/0 1 1 COM (1)
7 20 2.17 Yes + 1±1 HA 27/2/3/0 1 1 COM (3)
8 50 6.99 Yes ++ 4±1 HA 8/1/1/2 2 2 COM (2)
9 75 1.23 Yes +++ 4±2 HA 17/1/2/3 2 2 CaOx 95% (4)a
10 70 7.68 Yes ++ 1±1 HA, CaOx 13/1/1/10 2 2 COM (12)
11 10 1.76 No + 1±1 HA 5/1/0/2 1 1 COM 98%, HA 2% (4)
Abbreviations: % Papillary deformity, the fraction of papillae visualized at the time of surgery with deformity; % Plaque papillary surface area, mean percent of papillary
surface covered by white plaque; CaOx, calcium oxalate; COM, calcium oxalate monohydrate; Dilated BD, degree of dilatation of Bellini ducts; Glom, number of glomeruli/
mild/moderate/global sclerosis; HA, hydroxyapatite; IF, cortical interstitial fibrosis graded 1–3; IMCD/BD, inner medullary collecting duct+Bellini duct, mean number of
deposits per mm2 of tissue on m-CT; Stones attached to plaque, stones found attached to papilla on plaque at surgery; Tub At, cortical tubular atrophy, graded 1–3.
aSmall amount hydroxyapatite and acid ammonium urate in 1 stone each.
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Figure 3 |Relative densities of interstitial plaque and inner
medullary collecting duct (IMCD) deposits. (a, b) Large areas of
interstitial plaque (Randall’s) (arrows) are seen surrounding the
thin loops of Henle and extending to the base of the urothelial
cells (asterisk). (c, d) Areas of interstitial plaque (arrows) and
plugged IMCD (arrowheads) are found in the same biopsy sample
at varying amounts. None of these IMCD deposits contained
birefringent crystals. Interstitial fibrosis was associated with IMCD
plugs. Original magnification  100 (a, b);  50 (c, d).
a b
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Figure 4 | Inner medullary collecting duct (IMCD) deposits
mixture of apatite and calcium oxalate (CaOx). (a–d) Two
different large IMCD plugs from separate patients are seen under
nonpolarizing (a, c) versus polarizing (b, d) optics. These deposits
show birefringent (arrowheads) and nonbirefringent (single
arrows) crystals forming the same deposit, yet not admixed. The
nonbirefringent crystals are probably apatite and the birefringent
crystals CaOx. (e, f) An occasional small IMCD plug also possessed
both birefringent (see arrowheads in panels e, f) and
nonbirefringent (see single arrows in panels e, f) crystals. Original
magnification  25 (a–d);  100 (e, f).
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Overall, the SS values are reasonably consistent with the
predominance of CaOx in stones. As urine pH is generally
below 6 and SS with respect to CaP as brushite is below 1 in
almost all patient samples, the presence of abundant apatite
in IMCD deposits is unexplained.
DISCUSSION
Perhaps the most informative way to discuss these cases is in
relation to our earlier findings in patients with ileostomy and
bypass for obesity.1,3 As a group, the small bowel, ileostomy,
and bypass cases all formed similar numbers of stones per
patient year, that is, B1.1, 1.1, and 0.8, respectively. Surgical
procedure rates for stones of all bypasses and for the present
series were about 0.6 per patient year; for ileostomy it was 1.5
per patient year. In bypass cases and in the present series,
stones were essentially composed of only CaOx; ileostomy
patients formed stones composed of uric acid and CaOx.
At surgery, bypass patients displayed minimal papillary
abnormality, which consisted only of an occasional plugged
BD. Ileostomy patients displayed less papillary deformity
than the patients of this study, and about the same extent of
BD plugging; both markedly exceeded the minimal findings
in bypass patients. Histopathologically, IMCD and BD
deposits were far more marked in ileostomy patients than
in the present group (12 versus 2.2 deposits per mm2, 95%
confidence interval of difference 2–17.6, P¼ 0.02); among
bypass patients, we found the least of all, only a rare plugged
duct. Altogether, the three groups form a gradient of
pathology, bypass being the least involved, ileostomy the
most, and the cases presented here falling somewhere in
between. Only ileostomy patients formed uric acid stones.
Plaque, in our present series, was abundant; this is not
surprising as urine pH was low and urine volume was often
low. Moreover, as noted, urine volume would most likely
have been much lower at intervals of worsened diarrhea.
Compared with bypass, ileostomy, and routine CaOx SFs, as
well as normal people, the patients in this study fall between
ileostomy patients and normal subjects in pH and have the
lowest volume of ileostomy cases (Figure 6). Plaque
abundance is reasonable for their position on the three axes
of this plot. Bypass SFs have urine pH similar to that of
patients in this study, but of much higher volume and much
less plaque.
The stones are also not problematic. CaOx SS is high, and
we found CaOx stones growing over regions of apatite plaque.
Hence, unlike the complex problems raised by deposits, the
plaque and stones found here are in accord with, and help to
confirm, the model that we have presented elsewhere of plaque
formation with a scanty acidic urine3,7 and subsequent CaOx
stone overgrowth driven by urine CaOx SS.
The problem here, as in the other bowel diseases, is in
explaining apatite IMCD deposits when urine SS would lead
one to expect CaOx or uric acid deposits. In bypass cases, we
found that IMCD and BD plugs were almost invariably
apatite. CaOx was found only as a microscopic linear deposit
over the apical surfaces of a few IMCD cells in three of the
five patients, and in a small IMCD plug in two of these three
patients. Deposits in ileostomy patients were composed of
apatite and never of CaOx; we also found ammonium and
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Figure 5 |Micro-fourier-transformed infrared spectrometer
analysis of inner medullary collecting duct (IMCD) deposits.
IMCD deposits show a spectral band matching that of the
hydroxyapatite and calcite standards in patient no. 3 and calcium
oxalate (CaOx) standard in patient no. 4. Tissue with embedding
medium, a control, displays bands in common with the three
standards.
Table 3 | Urine results (24 h)
Patient Vol pH CIT Ca Ox NA UA NH4 SUL SS UA SS CaOx SS CaP Wt (kg)
1 1.70 5.41 324 117 57 137 430 42 23 1.31 9.70 0.18 75
2 0.66 6.05 80 158 43 86 376 64 28 1.10 26.90 3.10 57
3 2.38 5.53 248 243 57 272 506 69 37 1.00 8.81 0.36 59
4 1.68 5.61 50 69 35 182 460 52 21 1.07 4.03 0.09 57
5 0.75 5.67 89 88 21 63 258 31 7 1.42 10.2 1.10 50
6 1.13 5.27 260 75 142 239 453 63 27 2.37 17.03 0.18 100
7 1.13 5.28 128 117 44 174 507 39 33 2.62 10.59 0.21 91
8 2.47 5.70 354 37 104 222 512 36 24 0.70 3.25 0.07 86
9 2.36 5.93 434 208 44 178 349 39 23 0.36 6.36 0.84 61
10 0.85 5.14 56 33 62 121 280 42 41 2.34 11.77 0.05 58
11 1.96 5.61 40 148 106 250 627 53 33 1.28 14.5 0.39 77
Abbreviations: Ca, calcium (mg per day); CaOx, calcium oxalate; CaP, calcium phosphate; CIT, citrate (mg per day); Na, sodium (mEq per day); NH4, ammonium (mEq per day);
Ox, oxalate (mg per day); SS, supersaturation; SUL, sulfate (mEq per day); UA, uric acid (mg per day); Vol, volume (l per day).
Results are the mean of two collections for each patient.
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sodium salts of uric acid that could be explained by urine SS.
Here again, we find apatite in IMCDs of all patients; one
IMCD in each of the three cases had a plug containing CaOx
as well as apatite. Two of these plugs were very large, among
the largest IMCD plugs we found, and were vastly larger than
the CaOx plugs in our bypass patients. Given that stones were
composed of CaOx in all three groups, and sometimes of uric
acid in ileostomy cases, IMCD and BD apatite deposits have
always diverged from stones and urine SS.
How can we account for the divergence and differences
between these three groups? One approach is to consider
relevant urine chemistry values in relation to the kind of
IMCD deposits encountered. For this purpose, we compared
measurements in our 5 published cases of bypass surgery1,2
with measurements of 7 patients with ileostomy,3 as well as
with those of the 11 patients of this study, and, for reference,
with measurements obtained from 15 ICSFs2 who never form
any intratubular deposits (Table 4). Among these patients, as
noted, six (three bypass and three from the present cases)
have some CaOx in their IMCDs (Table 4, apatiteþCaOx).
Although SS CaOx does not vary among the four groups in
Table 4, those with CaOx deposits achieve their SS at a lower
molar ratio of calcium to oxalate than do the other three
groups. CaOx crystallization is known to be more efficient as
the molar ratio approaches 1.11 Although the numbers are
too small to establish these comparisons rigorously, these
urine data give some preliminary clue to a possible
pathogenetic mechanism for CaOx in IMCD plugs. Our
much larger report of patients who were not biopsied12 agrees
reasonably well with this table: molar ratios were 2.5 for bypass;
5.1 for small bowelþ colon resection; 5.2 for ileostomy; 5.8 for
small bowel resection alone; and 12.5 for routine SFs. Even so,
our results do not help explain IMCD apatite.
For apatite, the urine data are most remarkable in that SS
with at least one of the initial apatite precursors, brushite, is
always below 1 in the groups with deposits. As in the case of
urate species arising in a setting of urine chemistries that
favor uric acid, we presume and conjecture that CaOx or uric
acid was an initial phase, tubule pH increased secondary to
damage, and apatite became predominant. Urine pH for the
group with only apatite in deposits averaged 5.5, much below
that at which CaP phases would be stable. We recognize that,
at this stage, all we can offer is conjecture; we expect that
subsequent experiments by our laboratory and by other
laboratories will eventually clarify the actual mechanisms
involved in this very important example of crystal-mediated
cell injury. For urate species, the same sequence might
reasonably apply. Urate was found in five cases, all ileostomy.
Urine uric acid SS was far higher in these five patients than in
any other group (Table 4). We propose that uric acid was the
initial phase plugging IMCDs or BDs, and that urate species
became the more stable phase with time, perhaps because
Table 4 | Relationship between urine findings and IMCD deposits in patients with bowel disease or ICSF
No IMCD deposits (15) Apatite only (11) Apatite+CaOx (6) Apatite+UA (5)
SS CaOx 10±1 8±2 10±2 9±2
Ox 24* 41±7 64±8 69±11 32±12
[Ox] 0.3±0.1 0.4±0.1 0.5±0.1 0.3±0.1
Ca 24** 231±25 116±29 89±40 169±43
[Ca]** 4.2±0.4 1.7±0.5 1.8±0.7 3.8±0.8
[Ca]/[Ox]*** 14±1 6±2 3±2 11±2
pH** 5.84±0.1 5.5±0.1 5.6±0.1 5.3±0.1
SS UA*** 1.2±0.2 1±0.3 1±0.3 3±0.4
SS CaP 1±0.2 0.3±0.2 0.6±0.3 0.6±0.3
Abbreviations: CaOx, calcium oxalate; CaP, calcium phosphate; ICSF, idiopathic calcium stone formers (n=15); IMCD, inner medullary collecting duct; [Ox] and [Ca], oxalate and
calcium molarity (mmol/l); Ox 24 and Ca 24, 24 h urine oxalate and calcium (mg per day); SS, supersaturation; UA, uric acid.
Values are±s.e.m.
*, Values differ by analysis of variance (ANOVA) Po0.05; **, Po0.01; ***, Po0.001.
Bowel patients include all previously reported patients with bypass surgery for obesity (n=5), ileostomy (n=7), and current patients. One small bowel patient with apatite
IMCD deposits is missing from table (incomplete data).
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Figure 6 |Principle determinants of interstitial plaque. Normal
subjects (Normal) and idiopathic calcium oxalate stone formers
(CaOx) have urine pH (y axis) values near six, as well as similar
urine volumes (x axis), but the stone formers have much higher
calcium excretion (z axis, height) and abundant plaque (size
of symbol) compared with small amounts for normal subjects.
Bypass patients (Bypass) have normal amounts of plaque; low
urine calcium and high volume offset the low urine pH. Small
bowel resection (SBR) and ileostomy patients (Ileostomy) have
low urine pH and volume and normal calcium excretions, and
both form abundant plaque.
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intratubular pH increased secondary to injury to acidifica-
tion mechanisms from local plugging with obstruction. This
speculation requires further experimental confirmation.
We must presume that, because of their bowel diseases,
these patients suffered episodes of dehydration, which would
have radically altered SS. For ileostomy, the effects would
predictably be alkali loss and volume loss, with very acid-
scanty urine favoring uric acid and CaOx. For bypass patients
and in the present cases, prone to enteric hyperoxaluria, the
main prediction would be extreme CaOx SS. The latter could
seed IMCDs or BDs with initial CaOx plugs and entrain the
mechanisms we already alluded to.
Although we realize that our sample of patients with
bowel disease is relatively small, overall, the three groups of
patients lead us to a general hypothesis about enteric stone
disease that is perhaps most valuable in suggesting new
research. Ileostomy is a low volume low pH condition,
without enteric hyperoxaluria, which favors uric acid stones
and plugs and CaOx crystals, but at a higher calcium to
oxalate ratio than would be produced by enteric hyperox-
aluria. Bypass and small bowel disease create enteric
hyperoxaluria and would foster CaOx crystals more strongly
than ileostomy. We propose a sequence of local tubule injury
with reduced IMCD and BD acidification: initial plugging
occurs from phases favored in urine, CaOx, or uric acid;
crystal-mediated IMCD cell damage occurs; local IMCD and
BD fluid pH rises, along with CaP SS; and apatite forms. This
hypothesis is testable and may be fruitful.
MATERIALS AND METHODS
Patients
We studied 11 patients with small bowel resection and kidney stones
who required percutaneous nephrolithotomy at this institution
(International Kidney Stone Institute, Methodist Clarian Hospital,
Indianapolis, IN) during the past 6 years (Table 1) and who
consented to participate in the study. Clinical history was obtained
along with reviews of old records to obtain stone analyses (Table 2)
and the type and number of stone procedures.
Clinical measurements
Two 24-h urine samples were collected while patients were
consuming a diet of their choice and were off medications. In
urine, we measured volume, pH, calcium, oxalate, citrate,
phosphate, uric acid, sodium, potassium, magnesium, sulfate, and
ammonia using methods detailed elsewhere,13 and calculated SS
with respect to CaOx, brushite, uric acid, sodium acid urate, and
ammonium acid urate using EQUIL 2.14 Routine clinical blood
measurements were determined on blood samples drawn for clinical
purposes.
Biopsy protocol and plaque area determination
During percutaneous nephrolithotomy, all papillae were digitally
imaged as described elsewhere.1 Biopsy samples were taken from one
upper pole, interpolar, and lower pole papillum and from the cortex.
Using intraoperative recordings,7 the total surface area of each
papilla was measured, and one of us (JEL) outlined areas of white
(Randall’s) plaque, as well as the entire papilla, on one set of prints.
The white plaque and total papillary areas were converted to
number of pixels, giving the ratio of plaque to total papillary pixels,
or percentage coverage with plaque. No biopsy site inspected
intraoperatively displayed significant hemorrhage, and no post-
operative complications related to the biopsy procedures occurred in
any patient. The study was approved by the institutional review
board committee for Clarian Health Partners (no. 98-073).
Tissue analysis
Light microscopy analysis. In total, 31 papillary and 9 cortical
biopsies were studied using light microscopy. All biopsy specimens
were immersed in 5% paraformaldehyde in 0.1mol/l phosphate
buffer (pH 7.4) and were dehydrated through a series of graded
ethanol concentrations upto 100% ethanol before embedment in a
50/50 mixture of Paraplast Xtra (Fisher Scientific, Itasca, IL, USA)
and Peel-away Micro-Cut (Polysciences, Inc, Warrington, PA, USA).
Serial sections were cut into 4-mm-thick slices and stained with the
Yasue metal substitution method for calcium histochemistry15 and
with hematoxylin and eosin for routine histological examination. An
additional set of serial sections was cut at 7-mm thickness for
infrared analysis.
A renal pathologist (CLP) performed a semiquantitative analysis8
using the Jones’ silver-stained cortical sections from 9 of the 11 small
bowel patients. Each slide was given a code number to avoid patient
identification. Tubular atrophy and interstitial fibrosis were
independently scored on a scale of 0–3 (0¼ none, 1¼mild or
o34% of sample, 2¼moderate or 34–66%, and 3¼ severe or
466%). Glomerulosclerosis was defined as increased mesangial
matrix with or without wrinkling, thickening, and/or collapse of
glomerular basement membranes. Sclerosis of individual glomeruli
was scored as segmental (o25%¼mild; 25–75%¼moderate) or
global (475%¼ severe or total obsolescence). The total number of
glomeruli observed and the number of glomeruli in each of the three
categories of sclerosis were recorded.
Infrared analysis. Reflectance–absorption spectra were col-
lected with a Perkin–Elmer Spotlight 400 infrared imaging
microscope interfaced to a Perkin–Elmer Spectrum One FTIR
spectrometer (Perkin–Elmer, Shelton, Connecticut).5 The system
used a 100 100m liquid nitrogen-cooled mercury cadmium
telluride (HgCdTe) detector. Tissue samples were analyzed using
an aperture size appropriate to the size of the sample being studied
(for example, 50–20 mm in diameter). Each spectrum collected
represents the average of 64 or 128 individual scans possessing a
spectral resolution of 4 per cm. A clean area on the low-E slide was
used to collect the background spectrum.
Attenuated total internal reflection spectra were collected for all
tissue samples with a Perkin–Elmer Spotlight 400 infrared imaging
microscope interfaced to a Perkin–Elmer Spectrum One FTIR
spectrometer. The system used a 100 100m liquid nitrogen-cooled
HgCdTe detector. The standard germanium internal reflection
element was used in conjunction with a 100 100mm or a
50 50 mm aperture. As the attenuated total internal reflection
measurement is essentially an immersion measurement, the sampled
area using these apertures is 25 25m or 12.5 12.5 mm,
respectively. Each spectrum collected represents an average of 64
or 128 individual scans possessing a spectral resolution of 4 per cm.
A clean potassium chloride surface was used to collect the
background spectrum.
l-CT analysis
All papillary biopsy samples underwent m-CT analysis with the
SkyScan-1172 (SkyScan, Aartselaar, Belgium) high-resolution desktop
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m-CT system, allowing nondestructive mapping of the location
and size of the crystalline deposits within a biopsy specimen.5 This
m-CT system can generate a tissue window so that both the mineral
deposit and tissue organization are seen at the same time. For this
protocol, biopsy samples are quickly dipped in a 1:10 dilution of
Hypaque (50%, Nycomed, Princeton, NJ)/phosphate-buffered
saline, coated with a thin layer of paraffin, and mounted in the
center of a small chuck, which is then locked into place in the
machine. The sample was positioned in the center of the beam, and
the system configuration was set at 35 kV, 209mA, 1801 rotation,
with flatfield correction. Images were saved in compact disks and
reconstructed with cone-reconstruction software by SkyScan. These
images were then reconstructed into three-dimensional images with
SkyScan’s CTAnþCTVol software. These images allowed us to
properly orient each biopsy sample for future light microscopic
analysis. Three separate scans from each patient were used to
determine the number of sites of intraluminal deposits per square
millimeter.
Stones obtained from these patients were analyzed using the
SkyScan 1172 with reconstruction voxel sizes of 10–20 mm. Three-
dimensional reconstructions of stones were examined using ImageJ
(http://rsb.info.nih.gov/ij/) and Voxx2 (http://www.nephrology.
iupui.edu/imaging/voxx/) softwares to verify the composition.
Surface renderings were carried out using Amira program (Visage
Imaging, Carlsbad, CA).
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